Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
30 , 10551074.e8 (2019)
Obesity Drug Development: Still Room to Grow The second in our series of healthcare development reports focuses on the clinical and market needs within the GLP-1 space and how biopharma, investors and academia view the next obesity breakthrough
Improves Heart Health: Research has shown that Metformin reduces the risk of heart disease in people with Type 2 diabetes
Rarer but serious side effects include pancreatitis and risk of thyroid tumors, which a doctor should monitor for during the duration of the drugs use
US$ 22.60
US$ 25.11
US$ 28.11
US$ 27.18
